![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 40558 |
FusionGeneSummary for UBLCP1_CSNK1A1 |
![]() |
Fusion gene information | Fusion gene name: UBLCP1_CSNK1A1 | Fusion gene ID: 40558 | Hgene | Tgene | Gene symbol | UBLCP1 | CSNK1A1 | Gene ID | 134510 | 1452 |
Gene name | ubiquitin like domain containing CTD phosphatase 1 | casein kinase 1 alpha 1 | |
Synonyms | CPUB1 | CK1|CK1a|CKIa|HEL-S-77p|HLCDGP1|PRO2975 | |
Cytomap | 5q33.3 | 5q32 | |
Type of gene | protein-coding | protein-coding | |
Description | ubiquitin-like domain-containing CTD phosphatase 1CTD phosphatase-like with ubiquitin domain 1CTD-like phosphatase domain-containing proteinnuclear proteasome inhibitor UBLCP1 | casein kinase I isoform alphaCKI-alphaclock regulator kinasedown-regulated in lung cancerepididymis secretory sperm binding protein Li 77p | |
Modification date | 20180523 | 20180523 | |
UniProtAcc | Q8WVY7 | P48729 | |
Ensembl transtripts involved in fusion gene | ENST00000296786, | ENST00000261798, ENST00000377843, ENST00000515435, ENST00000504676, ENST00000515768, ENST00000606719, ENST00000606299, ENST00000515748, | |
Fusion gene scores | * DoF score | 2 X 2 X 2=8 | 7 X 5 X 6=210 |
# samples | 2 | 7 | |
** MAII score | log2(2/8*10)=1.32192809488736 | log2(7/210*10)=-1.58496250072116 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: UBLCP1 [Title/Abstract] AND CSNK1A1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation | Tumor suppressor gene involved fusion gene, in-frame but not retained their domain. Tumor suppressor gene involved fusion gene, retained protein feature but frameshift. DDR (DNA damage repair) gene involved fusion gene, in-frame but not retained their domain. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | UBLCP1 | GO:0006470 | protein dephosphorylation | 21949367 |
Tgene | CSNK1A1 | GO:0006468 | protein phosphorylation | 18305108 |
Tgene | CSNK1A1 | GO:0018105 | peptidyl-serine phosphorylation | 25500533 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | LIHC | TCGA-ZP-A9D4-01A | UBLCP1 | chr5 | 158696077 | + | CSNK1A1 | chr5 | 148876423 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000296786 | ENST00000261798 | UBLCP1 | chr5 | 158696077 | + | CSNK1A1 | chr5 | 148876423 | - |
Frame-shift | ENST00000296786 | ENST00000377843 | UBLCP1 | chr5 | 158696077 | + | CSNK1A1 | chr5 | 148876423 | - |
In-frame | ENST00000296786 | ENST00000515435 | UBLCP1 | chr5 | 158696077 | + | CSNK1A1 | chr5 | 148876423 | - |
In-frame | ENST00000296786 | ENST00000504676 | UBLCP1 | chr5 | 158696077 | + | CSNK1A1 | chr5 | 148876423 | - |
Frame-shift | ENST00000296786 | ENST00000515768 | UBLCP1 | chr5 | 158696077 | + | CSNK1A1 | chr5 | 148876423 | - |
Frame-shift | ENST00000296786 | ENST00000606719 | UBLCP1 | chr5 | 158696077 | + | CSNK1A1 | chr5 | 148876423 | - |
5CDS-intron | ENST00000296786 | ENST00000606299 | UBLCP1 | chr5 | 158696077 | + | CSNK1A1 | chr5 | 148876423 | - |
5CDS-intron | ENST00000296786 | ENST00000515748 | UBLCP1 | chr5 | 158696077 | + | CSNK1A1 | chr5 | 148876423 | - |
Top |
FusionProtFeatures for UBLCP1_CSNK1A1 |
![]() |
Hgene | Tgene |
UBLCP1 | CSNK1A1 |
Dephosphorylates 26S nuclear proteasomes, therebydecreasing their proteolytic activity. The dephosphorylation mayprevent assembly of the core and regulatory particles (CP and RP)into mature 26S proteasome. {ECO:0000269|PubMed:21949367}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | >UBLCP1 | chr5:158696077 | chr5:148876423 | ENST00000296786 | + | 2 | 11 | 3_81 | 51 | 319 | Domain | Ubiquitin-like |
Hgene | >UBLCP1 | chr5:158696077 | chr5:148876423 | ENST00000296786 | + | 2 | 11 | 133_294 | 51 | 319 | Region | Note=Phosphatase |
Tgene | CSNK1A1 | chr5:158696077 | chr5:148876423 | ENST00000377843 | - | 8 | 10 | 17_285 | 335 | 338 | Domain | Protein kinase |
Tgene | CSNK1A1 | chr5:158696077 | chr5:148876423 | ENST00000515768 | - | 9 | 11 | 17_285 | 363 | 366 | Domain | Protein kinase |
Tgene | CSNK1A1 | chr5:158696077 | chr5:148876423 | ENST00000377843 | - | 8 | 10 | 23_31 | 335 | 338 | Nucleotide binding | ATP |
Tgene | CSNK1A1 | chr5:158696077 | chr5:148876423 | ENST00000515768 | - | 9 | 11 | 23_31 | 363 | 366 | Nucleotide binding | ATP |
Top |
FusionGeneSequence for UBLCP1_CSNK1A1 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
>In-frame_UBLCP1_ENST00000296786_chr5_158696077_+_CSNK1A1_ENST00000261798_chr5_148876423_-_54aa >In-frame_UBLCP1_ENST00000296786_chr5_158696077_+_CSNK1A1_ENST00000515435_chr5_148876423_-_54aa >In-frame_UBLCP1_ENST00000296786_chr5_158696077_+_CSNK1A1_ENST00000504676_chr5_148876423_-_54aa |
* Fusion transcript sequences (only coding sequence (CDS) region). |
>In-frame_UBLCP1_ENST00000296786_chr5_158696077_+_CSNK1A1_ENST00000261798_chr5_148876423_-_162nt ATGGCTCTCCCTATCATTGTAAAATGGGGTGGACAGGAGTATTCAGTGACCACACTTTCAGAAGATGATACTGTGCTCGATCTCAAACAG >In-frame_UBLCP1_ENST00000296786_chr5_158696077_+_CSNK1A1_ENST00000515435_chr5_148876423_-_162nt ATGGCTCTCCCTATCATTGTAAAATGGGGTGGACAGGAGTATTCAGTGACCACACTTTCAGAAGATGATACTGTGCTCGATCTCAAACAG >In-frame_UBLCP1_ENST00000296786_chr5_158696077_+_CSNK1A1_ENST00000504676_chr5_148876423_-_162nt ATGGCTCTCCCTATCATTGTAAAATGGGGTGGACAGGAGTATTCAGTGACCACACTTTCAGAAGATGATACTGTGCTCGATCTCAAACAG |
* Fusion transcript sequences (Full-length transcript). |
>In-frame_UBLCP1_ENST00000296786_chr5_158696077_+_CSNK1A1_ENST00000261798_chr5_148876423_-_5144nt AGAGCGGCCACCCAGGGATCGGCGCTATCTGCACAGCGGTTACAGTCTCGGAAAGGCCTGGCTTCTTCGTGGCTTTGTGGAGATCCCTTA CAGCGGCCATTTGATTAGCACCCGAAGAGATTCAAAGGAAGCAGTTGTTCCGTCCCCAACATATTTCCGTTTCAAACCACCCACTTCCGG TTTTTCAGCCGGTTCCGGTCCCGCCCTTCACTTCCGGTCGCTTTCGGTCTCTCAGCGGCCGGTTTCTGCGTCCGCTGCCGCAGGTTCCAC CGCGCTCCAGGTATTTTTTTTTCTGAAGGAAAGCTGCTTCCTCATATGTTTCAAGAATGGCTCTCCCTATCATTGTAAAATGGGGTGGAC AGGAGTATTCAGTGACCACACTTTCAGAAGATGATACTGTGCTCGATCTCAAACAGTTTCTCAAGACCCTTACAGGAGTTCTTCCAGAAC GCCAAAAGTTACTTGGACTCAAAGTTAAAGGTTTCTAAGCATGAATTGAGGAACAGAAGAAGCAGAGCAGATGATCGGAGCAGCATTTGT TTCTCCCCAAATCTAGAAATTTTAGTTCATATGTACACTAGCCAGTGGTTGTGGACAACCATTTACTTGGTGTAAAGAACTTAATTTCAG TATAAACTGACTCTGGGCAGCATTGGTGATGCTGTATCCTGAGTTGTAGCCTCTGTAATTGTGAATATTAACTGAGATAGTGAAACATGG TGTCCGGTTTTCTATTGCATTTTTTCAAGTGGAAAAGTTAACTAAATGGTTGACACACAAAAATTGGTGGAGAAATTGTGCATATGCCAA TTTTTTGTTAAAACCTTTTGTTTTGAACTATACTGCTTTGAGATCTCATTTCAGAAGAACGGCATGAACAGTCTTCAGCCACAGTTGTGA TGGTTGTTAAATGCTCACAATTGTGCATTCTTAGGGTTTTTCCATCCCTGGGGTTTGCAAGTTGTTCACTTAAAACATTCTTAAAATGGT TGGCTTCTTGTCTGCAAGCCAGCTGATATGGTAGCAACCAAAGATTCCAGTGTTTGAGCATATGAAAGACTCTGCCTGCTTAATTGTGCT AGAAATAACAGCATCTAAAGTGAAGACTTAAGAAAAACTTAGTGACTACTAGATTATCCTTAGGACTCTGCATTAACTCTATAATGTTCT TGGTATTAAAAAAAAAGCATATTTGTCACAGAAATTTAGTTAACATCTTACAACTGAACATGTATGTATGTTGCTTAGATAAATGTAATC ACTGTAAACATCTATATGATCTGGGATTTTGTTTTTATTTTGAAATGGGAGCTTTTTTGTTTACAAGTTCATTAAAAACTAAAAACTGTT TCTGTAAGGAAATGAGATTTTTTTTAAACAACAAAAAATGCCTTGCTGACTCACTATTAAATAAAAATCTCCCCAATTTTTTGATAGACT ACTTCAAGCCATTTGTTACATGGTATTCCTTTGCAAGTCAATTTAGGTTTCGTGTTATAACTTTTCCTCTTTTTTTAAGAAAAATGAAAA AAGTAATTCTTTTGTCTGAAGGGGAAAGGCATTCTTTCATTTTTTTCTTTTTTTTTTTTTTTTTTTATGACTTGCAGGCACAATATCTAG TACTGCAACTGCCAGAACTTGGTATTGTAGCTGCTGCCCGCTGACTAGCAGCTGGACTGATTTTGAATAAAAATGAAAGCATTAAAGGGT TTCCCTACAAAACATTTTTCTTTAAAATACTTTTGAAATGGCTATAAGCAGTTGACTTTCACCCTTGGAGAGCATCACACTGTGTGAGGT TCAGTGATTGTTGACCCTCCCCAGCCCCTCCTGCTTCTTTAAGTTATCTGTGTGCGTGCGCTTCCTCTCAATCTTCTTTGCACGCTCATT TCTTTTTCTCTGACCCATGAGAAAGGAAAACTTACTGATGATAATTTTTAAATAGTGTAATTTATTCATTTATAGCATGTCAGGATAAAT TAAAAGAACATTTGTCTGGAAATGCTGCCGGGAGCCTATTGTGTAAATGTAGGTATTTTGTAAAATAACCTTGAAATTGTAAATTGACAC GTGTTTGGTCAGATTGTGTCAAGTTTAATTTGTTTTGTTTTCTTTTTTCTTTTTTTTATTTGAAAACTACTTTAGCAATAATTAATTCCA TGATTATCACATTCTGCCATTAAGGGATATTAGTACCGTAATACTGAAGAAATTTTATTAAGTCTGAACTTCTGGGGTAGGCAGCTTCTT TGTTTCTTTTCTATCCACCCTTGTCGGTTGAGGTATTTGTTTCTTGACTAATAAACCCTTTGATACTTTTAGCCAGAAATCAGTCTCATA AAGCTATTTTTGAGTATAGTTTGTGTAAAATAAAAATGTTTAGCTTTGGTAATAACTTCCAAGCTGAACTCCCTCTAGCAAGATATTTTT CAGTGCTTTTATTTACTATGCACTTAGACTATGCACTTTTTCTGAAATATTTTTGTAACACTTTTTTGTATTTTTGCCATTTGAAAAGGT TGTGGTGTAGTTGGTCTGTAATTAAGTTGCAGATTTAAAACTGCTGTTAGCTTTGTAAATCAAAATATAGGTGTTTTTTGTCCTGGTATA TCGTCATTCCATCTGCAGCTGGAGCTGGAATCCCATTGATCTTCTAGCTACCATTCATTTTCTTCACTGTTCACAAAAGAAGAGTGTGAA ATTCAGTGAATGCTGTTACTAATCCTGTTACGAGATGAATCTCATTTCACCAAAATTAAATTATGTTTTTCCGCTAAAATGATGATACAA GTTGAAGACACATCACTCTGAAATTGGAAGACCTCACCACTTAAGGCTCCACAGTGGCTTACTCAGCTGAACTCTAGGTTACTACTCTTT ACTTTGTTCACCCATTGGGGGGTGCAGTTTTTTTAAAATGTTGGGAGATGGCCATTCTAACTACTGTTGAATGTCTCTGTTTTGGGAAGG TATAACAAGAAATAAAAAAGAATATATATGAAGGGAGAGACTGGTTATCTCCTCCCATATGGTTGTGCTTATCCTCTTATGGCTTACAAA TGAATATTTGGAGGTTTGCTTTCACAATGATTTCCCATCAACAAATATTTTTAGTAGGATTTTTCCTGTTTCTGTTAGTCCTTGCAGTAC TCATAAATGTTTTAAGCTGAGCATACTGTAATAGTCATAAGTTTAATTTCATTATAATAAAAATAATCAAACAAAAGGACTTTAGAACCC AAGACAATGAGCTAGTTTTCCCTAAAGTTTGCTGAACTATTAAGGAATATGTTCTTATAGCTTTTGACTAGAATGAGTCATGGGAATTCT AAGAAGGGATGGCCTAGACATTTTTAGCTCAGTTAAATTCAGCATTTAATGCAGGTGAGTTCCTGGGTCGTTTTCCAACTAGTCTGGAAC AGTCTGGTTCTGACTCAAACTGGTATAAAGCATTATTTTAGGTTTTCTCTTTGCCAGTTTTTAAGCAGTTATAACCATGTAAATCAAGAT GTGAGGACATCTATATGAAGTATAGTAAAGAAGTGGTGTCAGCAGATCAATATGTGTGTCCTGGGTGTGCTGCTCTCTTAAGTGAGACTT TGTGAGACTATACTTTAAATGCATTATTACCATTGCTTACATTTTGGGGGATTTTCTTCCTCCTCAAAACTTCCATTTCTATTGTAATAT TCTTAATGACAATCTTTTTTTTTTTTTAGCAGTGTATGTTTGAAACAGCCAAAGATGGCGATGAACCAAGTGTAAATTGATCTAAGCAGC CCATGCAGTTTGTGTTGAATCAACAAACAGTGTATTGTTGAAGTGAAATTATTTTCTGAAATGACTTGTTAGACCAGTTTTGAGGACATA CTCAAAAGTAGAGTAATAATGGCTCCTGGGATGGAGAAATATGAGATGAACCTGGAACATTCTATTATGGTGCCACAAAGGAAATCTAAA AAAAAAAAAAAAAAAAAAAGTGGTTGGCTAGGAGCAGTGGCACACGCCTGTGATTCCAGCACTTTGGGAGGCCGAAGTGGGCAGGAGTTC AAGACCAGCCTGGCCAACATAGTGAAACCCTGTCTCTACTAAAAATACAAAAATTAGCCGGGTGTGGTGGCGGGCGCCTGTAATCCCAGC TTTTCAAGAGGCTGAGGCAGAAGAATCGCTTGAACCCGGGAGATGGAGGTTGCAGTGAGCTGAGATCGTGCCACTGCACTCCAGCCTGGG CGTTGCAGTGAGACTCCGTCTCAACAACAACAAAAAGGTGGATACATGTCAAAAGGGCACAGGAGCCACTTGAAGGATTATACTTGCTAA ATCTGTGTCAATTATCAAAATAAACTGGTAGCAACGTTACAACTCACTGAATAAGATACCATGATTCCATGTTGACTTAAAAATGGAGAG AAGAGAAAGCTCTAACTTGAATGTCAGCTAATTTAAGGTGAAAGGATTTTATGTGTTAGAAAAATCACCATTTTGCAAACTAGTTTTCAG AATCCTTAATATATGTCATCTCTTTTATTCCTCATAACAGTAATAAGAAACAGTTAACTGTTTCAGAAAAGAGTGGGGCTGCCCAAGGCA AGGCATGTTGGTAATTGGTAAGCTTTATAGAGCCAAGACCTCAACCTGATTTTCTTGCTTTCATGCAGTTAAGCCATGGTGCTCCTCTTG TTATATCACCCTTTTAAACCCAGAGATTGATAGTATTAGCCATCATTTGCTGAGTGTCATGCACTATTCTAAGTGCTTTACATGTATTTG CCTAATCAGCGCCCTGTGAAGTACATCCTGTCTCCATTTTGCATATAAGGATACCAAAGCACAGAGTTGGAGGGAAGATAGTTATATTCC CTTACTTTATTTATTTATTTTTTTGAGACAGGGTCTCGCACTGTCGCCCAGGCTTGAGTGCTATAAGACCTTAAGTTTCCCCTTTCAAAG TAGTTTATAGTGTCTAAATATCTTACATAAAAGTATATATCAAATAGGGTGGCAGTCTGGAAAGATTTAAAATCCAGAATGACTGGAAGG TTGGGCAACTAAGATTTCTTAAATTGCAGCTGTTTTCAACATAGATGTGTTGTAGAGTCTTTTCGGTTTCAAAATTAAATTGACTATAAA >In-frame_UBLCP1_ENST00000296786_chr5_158696077_+_CSNK1A1_ENST00000515435_chr5_148876423_-_1287nt AGAGCGGCCACCCAGGGATCGGCGCTATCTGCACAGCGGTTACAGTCTCGGAAAGGCCTGGCTTCTTCGTGGCTTTGTGGAGATCCCTTA CAGCGGCCATTTGATTAGCACCCGAAGAGATTCAAAGGAAGCAGTTGTTCCGTCCCCAACATATTTCCGTTTCAAACCACCCACTTCCGG TTTTTCAGCCGGTTCCGGTCCCGCCCTTCACTTCCGGTCGCTTTCGGTCTCTCAGCGGCCGGTTTCTGCGTCCGCTGCCGCAGGTTCCAC CGCGCTCCAGGTATTTTTTTTTCTGAAGGAAAGCTGCTTCCTCATATGTTTCAAGAATGGCTCTCCCTATCATTGTAAAATGGGGTGGAC AGGAGTATTCAGTGACCACACTTTCAGAAGATGATACTGTGCTCGATCTCAAACAGTTTCTCAAGACCCTTACAGGAGTTCTTCCAGAAC GCCAAAAGTTACTTGGACTCAAAGTTAAAGGTTTCTAAGCATGAATTGAGGAACAGAAGAAGCAGAGCAGATGATCGGAGCAGCATTTGT TTCTCCCCAAATCTAGAAATTTTAGTTCATATGTACACTAGCCAGTGGTTGTGGACAACCATTTACTTGGTGTAAAGAACTTAATTTCAG TATAAACTGACTCTGGGCAGCATTGGTGATGCTGTATCCTGAGTTGTAGCCTCTGTAATTGTGAATATTAACTGAGATAGTGAAACATGG TGTCCGGTTTTCTATTGCATTTTTTCAAGTGGAAAAGTTAACTAAATGGTTGACACACAAAAATTGGTGGAGAAATTGTGCATATGCCAA TTTTTTGTTAAAACCTTTTGTTTTGAACTATACTGCTTTGAGATCTCATTTCAGAAGAACGGCATGAACAGTCTTCAGCCACAGTTGTGA TGGTTGTTAAATGCTCACAATTGTGCATTCTTAGGGTTTTTCCATCCCTGGGGTTTGCAAGTTGTTCACTTAAAACATTCTTAAAATGGT TGGCTTCTTGTCTGCAAGCCAGCTGATATGGTAGCAACCAAAGATTCCAGTGTTTGAGCATATGAAAGACTCTGCCTGCTTAATTGTGCT AGAAATAACAGCATCTAAAGTGAAGACTTAAGAAAAACTTAGTGACTACTAGATTATCCTTAGGACTCTGCATTAACTCTATAATGTTCT TGGTATTAAAAAAAAAGCATATTTGTCACAGAAATTTAGTTAACATCTTACAACTGAACATGTATGTATGTTGCTTAGATAAATGTAATC >In-frame_UBLCP1_ENST00000296786_chr5_158696077_+_CSNK1A1_ENST00000504676_chr5_148876423_-_1287nt AGAGCGGCCACCCAGGGATCGGCGCTATCTGCACAGCGGTTACAGTCTCGGAAAGGCCTGGCTTCTTCGTGGCTTTGTGGAGATCCCTTA CAGCGGCCATTTGATTAGCACCCGAAGAGATTCAAAGGAAGCAGTTGTTCCGTCCCCAACATATTTCCGTTTCAAACCACCCACTTCCGG TTTTTCAGCCGGTTCCGGTCCCGCCCTTCACTTCCGGTCGCTTTCGGTCTCTCAGCGGCCGGTTTCTGCGTCCGCTGCCGCAGGTTCCAC CGCGCTCCAGGTATTTTTTTTTCTGAAGGAAAGCTGCTTCCTCATATGTTTCAAGAATGGCTCTCCCTATCATTGTAAAATGGGGTGGAC AGGAGTATTCAGTGACCACACTTTCAGAAGATGATACTGTGCTCGATCTCAAACAGTTTCTCAAGACCCTTACAGGAGTTCTTCCAGAAC GCCAAAAGTTACTTGGACTCAAAGTTAAAGGTTTCTAAGCATGAATTGAGGAACAGAAGAAGCAGAGCAGATGATCGGAGCAGCATTTGT TTCTCCCCAAATCTAGAAATTTTAGTTCATATGTACACTAGCCAGTGGTTGTGGACAACCATTTACTTGGTGTAAAGAACTTAATTTCAG TATAAACTGACTCTGGGCAGCATTGGTGATGCTGTATCCTGAGTTGTAGCCTCTGTAATTGTGAATATTAACTGAGATAGTGAAACATGG TGTCCGGTTTTCTATTGCATTTTTTCAAGTGGAAAAGTTAACTAAATGGTTGACACACAAAAATTGGTGGAGAAATTGTGCATATGCCAA TTTTTTGTTAAAACCTTTTGTTTTGAACTATACTGCTTTGAGATCTCATTTCAGAAGAACGGCATGAACAGTCTTCAGCCACAGTTGTGA TGGTTGTTAAATGCTCACAATTGTGCATTCTTAGGGTTTTTCCATCCCTGGGGTTTGCAAGTTGTTCACTTAAAACATTCTTAAAATGGT TGGCTTCTTGTCTGCAAGCCAGCTGATATGGTAGCAACCAAAGATTCCAGTGTTTGAGCATATGAAAGACTCTGCCTGCTTAATTGTGCT AGAAATAACAGCATCTAAAGTGAAGACTTAAGAAAAACTTAGTGACTACTAGATTATCCTTAGGACTCTGCATTAACTCTATAATGTTCT TGGTATTAAAAAAAAAGCATATTTGTCACAGAAATTTAGTTAACATCTTACAACTGAACATGTATGTATGTTGCTTAGATAAATGTAATC |
Top |
FusionGenePPI for UBLCP1_CSNK1A1 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
UBLCP1 | PSMD2, TSC22D4, PRPSAP1, ZFAND5, SHFM1, FSD1, NUDT6, ERP29, TARS, COLGALT1, PAAF1, PSMB2, PSMC1, PSMC2, PSMC3, PSMC4, PSMC5, PSMC6, PSMD1, PSMD11, PSMD12, PSMD13, PSMD14, PSMD3, PSMD4, PSMD6, PSMD7, PSMD8, UCHL5, GTF2E2, FGB, PSMD10 | CSNK1A1 | HMGB1, HMGB2, RCC1, PPP1R14A, SYT9, ERF, ADAP1, KPNA2, PPP2CA, ACTA1, AXIN1, TNFRSF1B, CHRM3, APC, PHLPP1, MDM4, MALT1, BCL10, NFKBIA, MDM2, TP53, E2F1, COPS5, ELAVL1, SH3KBP1, CDC25A, PDE4D, HSPA4, HSP90AA1, GLI3, MAPT, SNCA, PIP5K1A, CPSF6, PPP1CC, VCAM1, YWHAE, ITGA4, HNRNPC, GNB2, RPA3, RPA2, RPA1, FAM83G, BACH1, SEC16A, HMMR, CSNK1D, CSNK1E, SEC13, DYNLL1, ACACA, SEC23B, FAM83B, ZNF618, MZT2B, MZT2A, FAM83H, USP34, EPM2AIP1, DYNLL2, SNX22, UNC45A, FAM83D, RASAL2, DBR1, SNX24, EGFR, TIAM1, OCLN, SIK2, BTRC, C1orf111, NFATC3, TEX264, FAM170A, NTRK1, PCM1, CEP170, CEP128, CEP135, NIN, XPO1, CLTC, XRCC6, GTSE1, MYO18A, CARD11, NFATC1, SQSTM1, ATOH1, CRBN, CDH1, ZDBF2, SSMEM1, GAPVD1, POTEC, LRP5, HERC1, POTEB3, ARHGAP22, LRP6, TTC9C, NCKIPSD, WEE1, KCTD3, KIF13B, BCR, CGN, ZBTB21, DENND4C, KSR1, GIGYF1, CBY1, WDR92, FOXA1, TRIM25 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for UBLCP1_CSNK1A1 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for UBLCP1_CSNK1A1 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | CSNK1A1 | C0023493 | Adult T-Cell Lymphoma/Leukemia | 1 | CTD_human |
Tgene | CSNK1A1 | C0376634 | Craniofacial Abnormalities | 1 | CTD_human |